Design and evaluation of dihydroisoquinolines as potent and orally bioavailable human cytomegalovirus inhibitors

被引:14
|
作者
Chan, L [1 ]
Stefanac, T [1 ]
Turcotte, N [1 ]
Hu, ZH [1 ]
Chen, YM [1 ]
Bédard, J [1 ]
May, S [1 ]
Jin, HL [1 ]
机构
[1] Biochem Pharma Inc, Laval, PQ H7V 4A7, Canada
关键词
D O I
10.1016/S0960-894X(00)00265-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Following the identification of first pass metabolism issues with our recently described anti-HCMV compounds, the naphthyridines and isoquinolines, we have designed a class of novel metabolically stable and orally bioavailable anti-HCMV agents, the dihydroisoquinolines. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1477 / 1480
页数:4
相关论文
共 50 条
  • [31] Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors
    Thomson, Joanne L.
    Blackaby, Wesley P.
    Jennings, Andrew S. R.
    Goodacre, Simon C.
    Pike, Andrew
    Thomas, Steve
    Brown, Terry A.
    Smith, Alison
    Pillai, Gopalan
    Street, Leslie J.
    Lewis, Richard T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (08) : 2235 - 2239
  • [32] Discovery of potent and orally bioavailable 17β-hydroxysteroid dehydrogenase type 3 inhibitors
    Harada, Koichiro
    Kubo, Hideki
    Abe, Jun
    Haneta, Mari
    Conception, Arnel
    Inoue, Shinichi
    Okada, Satoshi
    Nishioka, Kazuhiko
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (10) : 3242 - 3254
  • [33] Discovery of β-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors
    Duan, James J. -W.
    Chen, Lihua
    Lu, Zhonghui
    Xue, Chu-Biao
    Liu, Rui-Qin
    Covington, Maryanne B.
    Qian, Mingxin
    Wasserman, Zelda R.
    Vaddi, Krishna
    Christ, David D.
    Trzaskos, James M.
    Newton, Robert C.
    Decicco, Carl P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (01) : 241 - 246
  • [34] Development of Novel Dual Binders as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors
    Hua, Zihao
    Bregman, Howard
    Buchanan, John L.
    Chakka, Nagasree
    Guzman-Perez, Angel
    Gunaydin, Hakan
    Huang, Xin
    Gu, Yan
    Berry, Virginia
    Liu, Jingzhou
    Teffera, Yohannes
    Huang, Liyue
    Egge, Bryan
    Emkey, Renee
    Mullady, Erin L.
    Schneider, Steve
    Andrews, Paul S.
    Acquaviva, Lisa
    Dovey, Jennifer
    Mishra, Ankita
    Newcomb, John
    Saffran, Douglas
    Serafino, Randy
    Strathdee, Craig A.
    Turci, Susan M.
    Stanton, Mary
    Wilson, Cindy
    DiMauro, Erin F.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (24) : 10003 - 10015
  • [35] Discovery and optimization of potent, selective, and orally bioavailable Jak1 inhibitors
    Zak, Mark
    Johnson, Adam
    Van Abbema, Anne
    Waszkowycz, Bohdan
    Eigenbrot, Charles
    Chang, Christine
    Hurley, Christopher
    Hanan, Emily
    Kenny, Jane
    Kulagowski, Janusz
    DeVoss, Jason
    Murray, Jeremy
    Balazs, Mercedesz
    Steffek, Micah
    Koehler, Michael
    Ghilardi, Nico
    Chakravarty, Paroma
    Lupardus, Patrick
    Gibbons, Paul
    Dragovich, Peter
    Bergeron, Philippe
    Pulk, Rebecca
    Mendonca, Rohan
    Savage, Scott
    Labadie, Sharada
    Gradl, Stefan
    Ward, Stuart
    Blair, Wade
    Jia, Wei
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [36] Design and optimization of renin inhibitors: Orally bioavailable alkyl amines
    Tice, Colin M.
    Xu, Zhenrong
    Yuan, Jing
    Simpson, Robert D.
    Cacatian, Salvacion T.
    Flaherty, Patrick T.
    Zhao, Wei
    Guo, Joan
    Ishchenko, Alexey V.
    Singh, Suresh B.
    Wu, Zhongren
    Scott, Boyd B.
    Bukhtiyarov, Yuri
    Berbaum, Jennifer
    Mason, Jennifer
    Panemangalore, Reshma
    Cappiello, Maria Grazia
    Harrison, Richard K.
    McGeehan, Gerard
    Dillard, Lawrence W.
    Baldwin, John J.
    Claremon, David A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [37] Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors
    Cheng, Dai
    Liu, Jun
    Han, Dong
    Zhang, Guobao
    Gao, Wenqi
    Hsieh, Mindy H.
    Ng, Nicholas
    Kasibhatla, Shailaja
    Tompkins, Celin
    Li, Jie
    Steffy, Auzon
    Sun, Fangxian
    Li, Chun
    Seidel, H. Martin
    Harris, Jennifer L.
    Pan, Shifeng
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (07): : 676 - 680
  • [38] Design and Synthesis of Orally Bioavailable Benzimidazoles as Raf Kinase Inhibitors
    Ramurthy, Savithri
    Subramanian, Sharadha
    Aikawa, Mina
    Amiri, Payman
    Costales, Abran
    Dove, Jeff
    Fong, Susan
    Jansen, Johanna M.
    Levine, Barry
    Ma, Sylvia
    McBride, Christopher M.
    Michaelian, Jonah
    Pick, Teresa
    Poon, Daniel J.
    Girish, Sandhya
    Shafer, Cynthia M.
    Stuart, Darrin
    Sung, Leonard
    Renhowe, Paul A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (22) : 7049 - 7052
  • [39] Design and optimization of renin inhibitors: Orally bioavailable alkyl amines
    Tice, Colin M.
    Xu, Zhenrong
    Yuan, Jing
    Simpson, Robert D.
    Cacatian, Salvacion T.
    Flaherty, Patrick T.
    Zhao, Wei
    Guo, Joan
    Ishchenko, Alexey
    Singh, Suresh B.
    Wu, Zhongren
    Scott, Boyd B.
    Bukhtiyarov, Yuri
    Berbaum, Jennifer
    Mason, Jennifer
    Panemangalore, Reshma
    Cappiello, Maria Grazia
    Mueller, Dominik
    Harrison, Richard K.
    McGeehan, Gerard M.
    Dillard, Lawrence W.
    Baldwin, John J.
    Claremon, David A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3541 - 3545
  • [40] Structure-based design and synthesis of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors
    Terasaka, T
    Okumura, H
    Tsuji, K
    Kato, T
    Nakanishi, I
    Kinoshita, T
    Kato, Y
    Kuno, M
    Seki, N
    Naoe, Y
    Inoue, T
    Tanaka, K
    Nakamura, K
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (11) : 2728 - 2731